Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Search

Top

PCI SYNTHESIS

UEI: KFEGN12NLNG1

PCI SYNTHESIS is a federal contractor, registered under UEI KFEGN12NLNG1. It has been awarded $75,900 across 1 federal contract. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

KFEGN12NLNG1

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$75.9K100%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$75.9K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in PCI SYNTHESIS's top NAICS codes and agencies

Oral Rehydration Powder Manufacturer

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

Sumatriptan Succinate Tablets Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

Supply of Tolnaftate Powder, USP 1%

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

Supply of Source-Controlled Spring Pins (NSN 5315-01-714-2822)

ASC COMMODITIES DIVISION

POSTED

about 21 hours ago

DEADLINE

RABIES VACCINE, VETERIN

Solicitation # SPE2DP-26-T-4904

This contract is for the procurement of IMRAB 3, a thimerosal-free, killed-virus veterinary rabies vaccine designed for three-year protection. The item is supplied by Boehringer Ingelheim Animal Health USA under part number 10391 and is issued in packages of 50 units. Strict storage requirements are mandated, requiring refrigeration between 2 and 8 degrees Celsius and a prohibition against freezing. The product has a non-extendable shelf life of 24 months and is regulated by the FDA. The order consists of one package under solicitation SPE2DP-26-T-4904, with delivery required within 84 days. All shipments must adhere to Medical Marking Standard No. 1 and DLA packaging requirements, with inspection and acceptance occurring at the destination. The contract is managed by the Department of Defense Medical Supply Chain Pharma FSA and includes specific technical and quality requirements as outlined in the DLA master list.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

POVIDONE-IODINE TOP

Solicitation # SPE2DP-26-T-4908

This contract is for the procurement of Povidone-Iodine Topical Solution, USP, 10 percent, in 1/2 fl oz bottles. The item is supplied in packages of 50 bottles per unit of issue. It is classified as a critical application item regulated by the FDA, with a total shelf life of 36 months and a requirement that at least 31 months of shelf life remain upon delivery to the government. The agreement specifies that packaging and labeling must adhere to Medical Marking Standard 1 and DLA packaging requirements. Delivery is set as FOB Destination to San Antonio, Texas, with a required delivery timeframe of five days. The contract includes specific quality and technical requirements from the DLA Master List and mandates that shipments be made via the fastest traceable means, explicitly prohibiting the use of parcel post.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

SODIUM CHLORIDE OPHTHA

Solicitation # SPE2DP-26-T-4900

This contract is for the procurement of five 16-ounce bottles of Sodium Chloride Ophthalmic Solution, used as an emergency buffered eyewash. The product is an FDA-regulated medical device that must adhere to USP standards and maintain a non-extendable shelf life of 36 months. Each unit must be properly sealed in commercial packaging capable of preventing damage and must be marked according to Medical Marking Standard No. 1, including the national stock number, manufacturer date, expiration or retest date, contract number, and lot number. The order is managed under solicitation SPE2DP-26-T-4900 with a delivery requirement of 20 days after order. Shipping is designated as FOB Destination to Joint Base Lewis MCCH in Washington, and must be sent via traceable means rather than parcel post. Compliance with DLA packaging requirements and the DLA Master List of Technical and Quality Requirements is mandatory, with specific adherence to ASTM D3951 for non-hazardous materials.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

APPLICATOR, SILVER NITR

Solicitation # SPE2DP-26-T-4903

This contract is for the procurement of silver nitrate applicators, which are prescription-only devices for topical use. Each applicator consists of a mixture of 75 percent silver nitrate and 25 percent potassium nitrate, measuring 6 inches in length. The items are issued in containers of 100 units and must be stored at room temperature in a dark, dry location away from oxidizable materials. The product is regulated by the FDA and has a non-extendable shelf life of 24 months. The order consists of one container with a delivery requirement of 20 days after receipt of order. Because the material is classified as hazardous, the supplier must provide a current Material Safety Data Sheet both to the DLA electronic mailbox and with each shipment. Packaging must comply with 49 CFR and ICAO technical regulations. The procurement is managed by the Department of Defense Medical Supply Chain Pharmacy FSA under solicitation SPE2DP-26-T-4903.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

TOLNAFTATE POWDER

Solicitation # SPE2DP-26-T-4905

This contract is for the procurement of Tolnaftate Powder USP 1% in 45 gram bottles, identified by NSN 6505014807897. The agreement includes two line items with quantities of one and six bottles respectively, to be delivered FOB destination to the USS Tucson. The required delivery timeframe is 20 days after the order is placed, with an original required delivery date of September 9, 2026. The supplier must adhere to strict quality and packaging standards, including the DLA Master List of Technical and Quality Requirements and Medical Marking Standard No. 1. The product is classified as a Type I item with a non-extendable shelf life of 36 months. Packaging must be commercial-grade and capable of protecting the contents from damage, with specific requirements for hazardous or non-hazardous materials according to FED-STD-313 and ASTM D3951.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

TEST STRIPS AND COLOR

Solicitation # SPE2DS-26-T-402H

This contract is for the procurement of three bottles of medical test strips and color charts used to detect bilirubin, blood, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen in urine. Each bottle contains 100 strips. The items must be delivered within 20 days after the order is placed. The supplies are subject to strict quality and packaging standards, including compliance with DLA packaging requirements and Medical Marking Standard No. 1. The product has a non-extendable shelf life of 18 months, and no more than two months may have elapsed from the date of manufacture to the date of delivery to the government. All labels must clearly display the contract number, lot number, and dates of manufacture and expiration.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 21 hours ago

DEADLINE

ISONIAZID TABLETS

Solicitation # SPE2DP-26-T-4901

This contract is for the procurement of Isoniazid Tablets USP, 300 mg, with a unit of issue consisting of bottles of 100 tablets. The order specifies a quantity of two bottles under NSN 6505001326904, with a required delivery date of September 8, 2026, and a delivery window of 20 days. The product is FDA regulated and must be stored at medical controlled room temperature, featuring a non-extendable shelf life of 36 months. The agreement mandates strict adherence to DLA packaging and marking standards, including Medical Marking Standard No. 1 and MIL-STD-129. Supplies must be delivered FOB destination to the USS Somerset LPD 25. Additionally, the contract prohibits the intentional addition of mercury or mercury-containing compounds to the hardware or supplies provided.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

SUMATRIPTAN SUCCINATE

Solicitation # SPE2DP-26-T-4909

This contract is for the procurement of Sumatriptan Succinate 25mg film coated tablets, used for the acute treatment of migraine in adults. The requirements specify a non-extendable shelf life of 24 months and strict storage conditions between 20 to 25 degrees Celsius, protected from light. The order consists of two separate purchase requests, each for a quantity of 9 units, with a required delivery date of September 8, 2026. The agreement mandates compliance with DLA packaging and marking standards, specifically MIL-STD-129 and MIL-STD-2073-1E, and requires shipment via traceable means to destinations at Fort Bliss, Texas, and Fort Hood, Texas. Delivery is set for 20 days after the order, with inspection and acceptance occurring at the destination. The contract is managed by the Department of Defense Medical Supply Chain Pharma FSA under solicitation number SPE2DP-26-T-4909.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 21 hours ago

DEADLINE

ANESTHESIA SET, EPIDURA

Solicitation # SPE2DS-26-T-401C

This solicitation from the Department of Defense Medical Supply Chain for Joint Base Charleston seeks one package of epidural anesthesia sets under NSN 6515-01-323-6531. Each package contains 10 units, with each set featuring a 20 GA catheter and a 17 GA Tuohy Schiff winged needle along with 29 total components. Delivery is required within 20 days after receipt of the order. The supplies must have a shelf life of 12 months, and no more than two months may have passed from the date of manufacture to the date of delivery to the government. Bidders are required to specify the source and part number being supplied and must adhere to DLA master technical, quality, and packaging requirements, including the removal of government identification from any non-accepted supplies.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 21 hours ago

DEADLINE

Radiopharmaceuticals

Solicitation # 36C25626Q1210

The Department of Veterans Affairs, specifically Network Contract Office 16, is seeking proposals for a combined contract regarding radiopharmaceuticals under solicitation number 36C25626Q1210. This opportunity is categorized under NAICS code 325412 and is open to all qualified bidders as there is no specific set-aside designated for this requirement. The contract will be performed in New Orleans, Louisiana. Interested parties must submit their responses by the deadline of September 18, 2026, at 3:00 PM. The primary point of contact for this procurement is Veronica Maskell, who can be reached via email or phone for further inquiries.

256-NETWORK Contract Office 16 (36C256)

POSTED

DEADLINE

Intent to Sole Source Coagulation Analyzer System

Solicitation # FA860126Q0136

The Airforce Life Cycle Management Center intends to award a sole-source, firm-fixed-price contract to Werfen USA LLC for the acquisition of Automated Coagulation Analyzer Systems for the 88th Medical Center at Wright-Patterson Airforce Base. This procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. The government has determined that Werfen is the only responsible source capable of meeting the requirements, as they are the sole provider and servicer of ACL TOP analyzers in the United States. The decision to bypass full and open competition is based on the need for specific technical capabilities, including 671 nm wavelength technology and direct Sarstedt tube compatibility, to avoid costly sample re-draws and extensive laboratory information system integration. Standardizing with Werfen ensures seamless continuity and eliminates the need for technician retraining. Interested parties may submit capability statements or exceptions to the sole source intent to the designated points of contact by September 9, 2026.

FA8601 Aflcmc Pzio

POSTED

DEADLINE

36E79726R0032 Lisinopril Tablets (VA-27-00004937)

Solicitation # 36E79726R0032

The Department of Veterans Affairs is conducting an unrestricted procurement under solicitation 36E79726R0032 to secure an uninterrupted source of supply for Lisinopril Tablets. This contract supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror for a base period of one year, with four pre-priced one-year option periods. The procurement is issued in a commercial item format in accordance with FAR Part 12, with a tentative solicitation release date of September 3, 2026, and a response deadline of September 24, 2026. The scope of work includes the supply of Lisinopril tablets in various strengths ranging from 2.5mg to 40mg, with specific annual quantity requirements for various bottle sizes. Strict packaging and labeling standards are mandated, requiring a unique NDC number and the exact drug name on the label. For specific unit-of-use packaging, bottles must be cylindrical with a minimum 120cc volume and a 5.75 inch circumference to accommodate a 5.25 by 2 inch label. Additionally, these bottles must feature a safety cap that is either convertible or deshellable. The contractor's label must be the only label on the product and must allow VA labels to adhere securely on top. All proposals and communications are handled electronically via SAM.gov.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9403

The Defense Health Agency, acting for the Department of War, is soliciting quotations under solicitation HT9402-26-Q-9403 to establish Uniform Formulary Blanket Purchase Agreements and Additional Discount Program Agreements. This initiative aims to create an integrated pharmacy benefits program for the Military Health System by evaluating the clinical and cost effectiveness of pharmaceutical agents. The process involves the Pharmacy and Therapeutics Committee reviewing specific drugs for placement on the Uniform Formulary, including Furoscix ReadyFlow, Gwyn Lo, Jideytro, Omlyclo, RizaFilm, and Zenbexus. Interested parties must adhere to a strict timeline, including a pre-quotation teleconference on September 9, 2026, with a final response deadline of September 24, 2026. Clinical questions and quotes must be submitted to the designated points of contact, Stephanie Erpelding and Keith Marasigan. The procurement falls under NAICS code 325412 and is managed out of Aurora, Colorado, with no specific set-aside restrictions applied to this solicitation.

Defense Health Agency

POSTED

DEADLINE

FDA-Approved Radiopharmaceutical Supplies and Cold Kits

Solicitation # HT9406-26-Q-E102

The Defense Health Agency is soliciting a firm-fixed-price contract for the continuous provision, custom compounding, and timely delivery of 61 FDA-approved radiopharmaceuticals and cold kits to the Nuclear Medicine Section at the Dwight David Eisenhower Army Medical Center (DDEAMC) in Fort Gordon, Georgia. The contract structure consists of a one-year base period and four optional one-year extensions, running through September 30, 2031. The contractor is responsible for providing all necessary personnel, equipment, and transportation to ensure the delivery of these short half-life materials, including the capability to execute emergency deliveries within two hours of order acceptance on a 24/7/365 basis. Award will be based on the Lowest Price Technically Acceptable (LPTA) process. To be deemed technically acceptable, offerors must possess an active NRC or Agreement State radioactive materials license, FDA Blood Establishment compounding registration, and CLIA certifications. Additionally, the compounding pharmacy must be located within a 90-minute driving radius of DDEAMC to meet strict 30-minute pre-calibration delivery windows. All operations must strictly adhere to FDA, NRC, DOT, and HIPAA regulations, with 100 percent inspection upon receipt by medical staff. Payment will be processed via Electronic Funds Transfer through the Wide Area Workflow system.

Defense Health Agency

POSTED

DEADLINE